China stocks rise, tech indexes book biggest quarterly gains in a year
** Shares in China's semiconductor firms jumped on expectations of robust earnings growth in the first half as a shortage of semiconductors pushed prices higher. ** Shenzhen Fine Made Electronics Group Co Ltd, Kingsemi Co Ltd, Sino Wealth Electronic Ltd and SG Micro Corp rose between 11% and 20%.

- Country:
- China
China stocks ended higher on Wednesday, with major tech indexes booking their biggest quarterly gains in a year on policy support from Beijing and strong earnings expectations. ** The blue-chip CSI300 index rose 0.7% to 5,224.04, while the Shanghai Composite Index firmed 0.5% to 3,591.20, also aided by soft factory activity data that soothed fears of policy tightening.
** Shenzhen's start-up board ChiNext climbed 2.1% to a six-year high, while Shanghai's tech-focused STAR50 index rose 1.7%. ** For the quarter, the CSI300 gained 3.5% and the SSEC climbed 4.3%.
** ChiNext jumped 26% for the quarter, while STAR50 advanced 27%, both posting their best quarterly gains in a year. ** Shares in China's semiconductor firms jumped on expectations of robust earnings growth in the first half as a shortage of semiconductors pushed prices higher.
** Shenzhen Fine Made Electronics Group Co Ltd, Kingsemi Co Ltd, Sino Wealth Electronic Ltd and SG Micro Corp rose between 11% and 20%. ** The CSI all-share semiconductors & semiconductor equipment index climbed 4.8%.
** Analysts attributed the tech strength to Beijing's policy support amid Sino-U.S. tech competition and rosy earnings growth in the first half. ** Semiconductors, as a new type of strategic resource, are pivotal to China's economic development in coming decades, BOC International (China) said in a report, noting price hikes in the semiconductor sector.
** Growth in China's June factory activity dipped to a four-month low on higher raw material costs, a shortage of semiconductors and a COVID-19 outbreak in the major export province of Guangdong, amid wider supply chain disruptions in Asia. ** China's economic growth could be weak in the second half, indicating a neutral monetary policy with a loosening bias would continue, Essence Securities said in a report, adding weak growth could substantially decrease chances of monetary tightening.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Sinopharm unit gets approval for clinical trials of mRNA COVID vaccine
Health News Roundup: Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer's drug; Sinopharm unit gets OK for clinical trials of mRNA COVID vaccine and more
'Las Vegas of the Alps' to vote on casino ban
Sinopharm unit gets OK for clinical trials of mRNA COVID vaccine
Liechtenstein votes resoundingly against banning casinos